Read our COVID-19 research and news.

A massive influx of money and people is needed immediately to stop Ebola, says Bruce Aylward.

A massive influx of money and people is needed immediately to stop Ebola, says Bruce Aylward.

© PIERRE ALBOUY/Reuters/Corbis

Ebola: 'Wow, that is really tough'

Bruce Aylward is used to mobilizing armies of health workers. An assistant director-general at the World Health Organization (WHO) in charge of polio and emergencies, he leads the massive global effort to eradicate the poliovirus. But Aylward says he has never encountered a challenge as great as the Ebola outbreak in West Africa, which has infected more than 4000 people and killed more than 2000. Margaret Chan, who heads WHO, asked Aylward to help with the response in August; since then, he has been running operations and helped draw up WHO’s Ebola Response Roadmap, released on 28 August. He spoke with Science on 4 September. (This interview has been edited for clarity and brevity.)

Q: Margaret Chan has said that all organizations involved in the outbreak, including WHO, underestimated its complexity and magnitude. How did this happen?

A: I didn't live through it all, but as I've gone back and  asked what was happening, clearly these guys [in the response effort] have been flat-out on this for 6 months. And they’ve put 450 people in the field. Those are unheard-of numbers in responding to Ebola. But the virus got ahead of them.

Could the response have been scaled up faster? Maybe they were off by 2 weeks at one point here or there. As Margaret says, you're always a couple of weeks behind this virus, and there are so many reasons why. It's a dangerous pathogen. Foreign medical teams and NGOs [nongovernmental organizations] are used to dealing with trauma and primary health care; they're not trained to deal with  pathogens.

Q: I’ve heard there are tensions between WHO and Doctors Without Borders (MSF), the organization that has treated more patients than any other. They have criticized WHO for being too slow and doing too little.

A: Probably at local levels there's some tension in some places, but certainly not here, in Geneva at senior levels. There's a great respect for the organization. MSF is great at two things: They're fantastic at their field operations and at telling the rest of us how bad we are at them. Sure, people are going to go out and say, “Oh, that's unfair.” You have to have a tough skin. You're in the World Health Organization; you’re dealing with a major international threat, and our job is to be accountable. And if MSF feels that this is public accountability, it's their right.

Q: Why is stopping this outbreak so hard compared with controlling polio?

A: The polio program is really tough because of the level of programmatic perfection you need. You have to get to every single kid with vaccine over a huge geography and in very challenging environments. But even if you don’t, you still have a level of control over the virus. Now, when I look at Ebola, you need a whole other level of perfection.

You have to do perfect contact tracing, because one contact can blow open a whole new chain of transmission. You have to get your burials perfectly safe. You have to get your laboratory testing right. There isn't a lot of capacity in the world on that. You have to get your social messages right. You have to be perfectly safe and protect health care workers. And you have to do all this in incredibly weak environments, in three countries that are near the bottom of the development index, and also deal with the embers that land in Nigeria or in Senegal. Wow, that is really tough.

Q: Do you think it’s still possible to contain the outbreak with the standard procedures—isolating patients, tracing contacts, burying the dead safely?

A: Absolutely. But with an important difference. What’s happened is you’ve got a caseload that far exceeds the capacity of the standard Ebola strategies to manage them, so you have to innovate on these strategies. Each infected person is having a heap of contacts because they’re basically being left in their communities for long periods of time. What you’ve got to do is first of all cut down the outward spread from every patient, which means you’ve got to get many new Ebola treatment centers up. And you’ve got to adapt your strategies in a way that communities can play a much bigger role and help them scale up their own Ebola community care units. This is absolutely critical and must be done in September.

Will it be done? Well, that’s going to depend on whether the international community will put the money on the table, help the people get in, and understand the conditions they need to operate.

Q: WHO's Ebola road map calls for the epidemic to be ended in 6 to 9 months. Isn't that overly optimistic?

A: I don’t know, because no one’s ever had to do something on this scale before. What I do know is if this road map is not implemented, you’re not going to stop it in 6 to 9 months. In 1 month you need at least 10 new facilities operational with additional bed capacity and teams on the ground, and money so that people doing this stuff are getting paid, and a way to evacuate the responders that get into medical trouble there. You have to start implementing the road map today.

But the usual relief organizations aren't lining up to do it. These aren’t bad people and these aren’t cowards. These are people who go into the most dangerous operating environments—wars and natural disasters. But they don’t normally deal with hazardous pathogens.

Q: So you need more people and you need more money, but it's simply not coming?

A: Not yet, but I’m optimistic. I think it’s taking the world time to grapple with this. It is so new, and it plays to people’s deepest fears and their greatest uncertainties. People will learn MSF is going to stay on the ground there. And then one or two NGOs are going to go in and run a facility, and they’re going to do fine. And then it’s going to escalate. The world doesn’t want to be beaten by a pathogen. But the question is: Are they going to do it fast enough?

Q: So who are the players that you hope will come to build and run treatment centers?

A: A lot of foreign medical teams are linked to governments, and some affected countries have deep relationships: the U.S. with Liberia; the U.K. with Sierra Leone; France with Guinea. Now those countries are very keen to look at what they can do and how to do it, but they are having trouble mobilizing. They might be able to put up a field hospital, but can they staff it? Because a field hospital that’s not staffed is just one more building, that’s not an Ebola treatment center.

Q: Two vaccine candidates are soon going to be tested in phase I studies and may be deployed later this year. How important do you think they and candidate drugs will be for ending the epidemic?

A: You want to have as many tools as possible to help drive down that reproductive number to where you can manage it with traditional strategies. You want to do both things in parallel and go flat-out. The vaccines and new therapies would be hugely helpful—they would help get responders in and keep the responders that are there healthy. That may give us an edge to shut this thing down more quickly. But if we say we need these drugs and vaccines, then you’re setting yourself up for defeat because you might not get them. And then you also have the risk of people saying: "There’s going to be a vaccine or med, let’s wait," and then an awful lot of people are going to die. I’m not going to sit around twiddling my thumbs waiting to find out, and neither is my organization.

*The Ebola Files: Given the current Ebola outbreak, unprecedented in terms of number of people killed and rapid geographic spread, Science and Science Translational Medicine have made a collection of research and news articles on the viral disease freely available to researchers and the general public.